Showing 1 - 10 of 102
Persistent link: https://www.econbiz.de/10013479760
There is a paucity of economic evidence relating to interventions for peripheral nerve disorders and the aim of this study was to illustrate the application of economic evaluation in this area by making a comparison of the cost-effectiveness of intravenous immunoglobulin and prednisolone...
Persistent link: https://www.econbiz.de/10009440537
The COVID-19 pandemic and its mobility restrictions have been an external shock, influencing wellbeing. However, does risk exposure affect the welfare effect of lockdowns? This paper examines the 'welcomed lockdown' hypothesis, namely the extent to which there is a level of risk where mobility...
Persistent link: https://www.econbiz.de/10013353408
Persistent link: https://www.econbiz.de/10004877681
Persistent link: https://www.econbiz.de/10004802861
At present six million people are suffering from clinical depression or anxiety disorders, but only a quarter of them are in treatment. NICE Guidelines prescribe the offer of evidence-based psychological therapy, but they are not implemented, due to lack of therapists within the NHS. We...
Persistent link: https://www.econbiz.de/10005151004
Persistent link: https://www.econbiz.de/10001463986
Persistent link: https://www.econbiz.de/10001323982
Persistent link: https://www.econbiz.de/10001342393
Persistent link: https://www.econbiz.de/10001330030